Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
A partir d'échantillons prélevés sur des patients atteints d'un glioblastome, cette étude évalue l'intérêt d'une méthode permettant d'isoler et de caractériser des populations clonales tumorigéniques et ayant développé une résistance thérapeutique
Glioblastoma (GBM) is a cancer comprised of morphologically, genetically, and phenotypically diverse cells. However, an understanding of the functional significance of intratumoral heterogeneity is lacking. We devised a method to isolate and functionally profile tumorigenic clones from patient glioblastoma samples. Individual clones demonstrated unique proliferation and differentiation abilities. Importantly, naïve patient tumors included clones that were temozolomide resistant, indicating that resistance to conventional GBM therapy can preexist in untreated tumors at a clonal level. Further, candidate therapies for resistant clones were detected with clone-specific drug screening. Genomic analyses revealed genes and pathways that associate with specific functional behavior of single clones. Our results suggest that functional clonal profiling used to identify tumorigenic and drug-resistant tumor clones will lead to the discovery of new GBM clone-specific treatment strategies.
Proceedings of the National Academy of Sciences , article en libre accès, 2015